Search

Your search keyword '"Jiménez-Fonseca, Paula"' showing total 405 results

Search Constraints

Start Over You searched for: Author "Jiménez-Fonseca, Paula" Remove constraint Author: "Jiménez-Fonseca, Paula"
405 results on '"Jiménez-Fonseca, Paula"'

Search Results

2. Dynamic nature of BRAF or KRAS p.G12C mutations in second-line therapy for advanced colorectal cancer patients: do early and late effects exist?

3. Impact of systemic cancer treatment on quality of life and mental well-being: a comparative analysis of patients with localized and advanced cancer

4. Catheter – related thrombosis in cancer patients: Data from the registry of thrombosis and nEoplasia of SEOM (TESEO)

5. CRISPR/dCAS9-mediated DNA demethylation screen identifies functional epigenetic determinants of colorectal cancer

7. Management of liver and gastrointestinal toxicity induced by immune checkpoint inhibitors: Position statement of the AEEH–AEG–SEPD–SEOM–GETECCU

10. Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial

11. Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial

12. Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first-line treatment for advanced or metastatic oesophageal squamous cell carcinoma (RATIONALE-306): a global, randomised, placebo-controlled, phase 3 study

13. Hemicolectomy versus appendectomy for patients with appendiceal neuroendocrine tumours 1–2 cm in size: a retrospective, Europe-wide, pooled cohort study

16. Incidence, risk factors, and evolution of venous thromboembolic events in patients diagnosed with pancreatic carcinoma and treated with chemotherapy on an outpatient basis

26. Usefulness of an immunohistochemical score in advanced pancreatic neuroendocrine tumors treated with CAPTEM or everolimus

27. Metabolomic profile of neuroendocrine tumors identifies methionine, porphyrin, and tryptophan metabolisms as key dysregulated pathways associated with patient survival

29. Psychometric Properties of the PDRQ-9 in Cancer Patients: Patient-Doctor Relationship Questionnaire /Propiedades Psicometricas del PDRQ-9 en Pacientes con Cancer: Cuestionario de Relacion Medico-Paciente

30. A snapshot of cancer-associated thromboembolic disease in 2018–2019: First data from the TESEO prospective registry

32. Nab -Paclitaxel plus Gemcitabine and FOLFOX in Metastatic Pancreatic Cancer

37. Toxicities and Quality of Life during Cancer Treatment in Advanced Solid Tumors

38. Coping strategies as mediators of uncertainty and psychological distress in patients with advanced cancer

39. Clinicians’ and Advanced Cancer Patients’ Estimates of Treatment Efficacy and Toxicity in Oncologic Treatment

41. Efficacy and safety of chemotherapy in older versus non-older patients with advanced gastric cancer: A real-world data, non-inferiority analysis

44. Quality of Life and Psychological Distress in Advanced Cancer Patients: Associations with Sociodemographic and Clinical Factors

47. Metabolomic profile of neuroendocrine tumors identifies methionine, porphyrin, and tryptophan metabolisms as key dysregulated pathways associated with patient survival.

48. The Relationship between Therapeutic Alliance and Quality of Care in Patients with Advanced Cancer in Spain

49. Mental Adjustment, Functional Status, and Depression in Advanced Cancer Patients

Catalog

Books, media, physical & digital resources